Expertise in
1
conditions

Martine Klausmann

Aschaffenburg, BY, DE 
Expertise in
1
conditions
Aschaffenburg, BY, DE 

Overview

Martine Klausmann practices practicing medicine in Aschaffenburg, Germany.

Ms. Klausmann is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Myeloproliferative Neoplasms (MPN), Acute Myelomonocytic Leukemia, Chronic Myelogenous Leukemia (CML), Leukemia, and Splenectomy.

She is actively involved in clinical research, co-authoring 11 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Aschaffenburg, BY, Germany
Other Locations
Leipzig, SN, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Treatment Optimization of Newly Diagnosed Ph/BCR-ABL Positive Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase With Nilotinib vs. Nilotinib Plus Interferon Alpha Induction and Nilotinib or Interferon Alpha Maintenance Therapy
Treatment Optimization of Newly Diagnosed Ph/BCR-ABL Positive Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase With Nilotinib vs. Nilotinib Plus Interferon Alpha Induction and Nilotinib or Interferon Alpha Maintenance Therapy
Enrollment Status: Completed
Publish Date: May 10, 2023
Intervention Type: Drug
Study Drugs: Peginterferon ?2b, Nilotinib
Study Phase: Phase 3

11 Total Publications

Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX).
Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX).
Journal: Leukemia
Published: October 28, 2025

Frequently Asked Questions about Martine Klausmann

Is Martine Klausmann a top-rated expert for Myeloproliferative Neoplasms (MPN)?

MediFind is an objective health platform that identifies experts based on real-world data. Martine Klausmann is classified as an Advanced expert for Myeloproliferative Neoplasms (MPN), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Martine Klausmann participate in research or clinical trials?

Yes. Martine Klausmann has published 11 articles and abstracts on conditions like Myeloproliferative Neoplasms (MPN). You can view a list of Martine Klausmann's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Klausmann's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile